FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1068011000001101: Hyoscine butylbromide 10mg tablets 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22496301000001113 Hyoscine butylbromide 10mg tablets 20 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22496401000001117 Hyoscine butylbromide 10mg tablets 20 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine butylbromide 10mg tablets 20 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Is pack of Product containing precisely scopolamine butylbromide 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Has active ingredient Scopolamine butylbromide false Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Has VMP Product containing precisely scopolamine butylbromide 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Has specific active ingredient Scopolamine butylbromide true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 10mg tablets 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Buscopan IBS Relief 10mg tablets (Boehringer Ingelheim Ltd) 20 tablet 2 x 10 tablets Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier
Buscopan 10mg tablets (Boehringer Ingelheim Ltd) 20 tablet Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier
Buscopan 10mg tablets (PI) (Dowelhurst Ltd) 20 tablet Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier
Buscopan 10mg tablets (PI) (Waymade Ltd) 20 tablet Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier
Buscopan 10mg tablets (Doncaster Pharmaceuticals Ltd) 20 tablet Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier
Buscopan 10mg tablets (Sigma Pharmaceuticals Plc) 20 tablet Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier
Buscopan Cramps 10mg tablets (Boehringer Ingelheim Self-Medication Division) 20 tablet 2 x 10 tablets Is a True Hyoscine butylbromide 10mg tablets 20 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start